Search

Your search keyword '"ADC Therapeutics S.A. -- Forecasts and trends"' showing total 4 results
Start Over Descriptor "ADC Therapeutics S.A. -- Forecasts and trends" Journal globenewswire
4 results on '"ADC Therapeutics S.A. -- Forecasts and trends"'

1. Antibody Drug Conjugates Market Revenue to Hit $29.6 Billion, Globally, by 2030 - Exclusive Study by The Insight Partners

Subjects
Astellas Pharma Inc. -- Forecasts and trends, ADC Therapeutics S.A. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Insight Partners -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Antineoplastic agents -- Reports -- Forecasts and trends, Biological products -- Reports -- Forecasts and trends, Venture capital companies -- Forecasts and trends, Monoclonal antibodies -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Antimitotic agents -- Reports -- Forecasts and trends, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

Pune, India, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Antibody drug conjugates (ADC) are one of the fastest growing anticancer drugs. It is typically composed of a monoclonal antibody (mAbs) covalently [...]

Published
2023

2. Global Antibody Drug Conjugates (ADC) Market Analysis Report 2022: A $13.8 Billion Market by 2028 - Increased Investments by Key Industry Players

Subjects
United States. Food and Drug Administration -- Statistics -- Reports, ADC Therapeutics S.A. -- Forecasts and trends, Seagen Inc. -- Forecasts and trends, Biopharmaceutics -- Statistics, Biotechnology industry -- Forecasts and trends -- Statistics, Viral antibodies -- Statistics -- Reports -- Forecasts and trends, Antibodies -- Statistics -- Reports -- Forecasts and trends, Pharmaceutical industry -- Statistics -- Forecasts and trends, Investments -- Statistics, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

Dublin, Sep 08, 2022 (GLOBE NEWSWIRE via COMTEX) -- EQNX::TICKER_START EQNX::TICKER_END The 'Global Antibody Drug Conjugates Market Size, Share & Industry Trends Analysis Report By Application, By Technology, By Regional [...]

Published
2022

3. The Global Antibody Drug Conjugates Market size is expected to reach $13.8 billion by 2028, rising at a market growth of 14.2% CAGR during the forecast period

Subjects
United States. Food and Drug Administration -- Statistics -- Reports, Merck & Company Inc. -- Forecasts and trends, Astellas Pharma Inc. -- Forecasts and trends, Takeda Pharmaceutical Company Ltd. -- Forecasts and trends, ADC Therapeutics S.A. -- Forecasts and trends, GSK PLC -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Gilead Sciences Inc. -- Forecasts and trends, Seagen Inc. -- Forecasts and trends, Daiichi Sankyo Company Ltd. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Biological products industry -- Statistics -- Forecasts and trends, Biopharmaceutics -- Statistics, Biotechnology industry -- Forecasts and trends -- Statistics, Viral antibodies -- Statistics -- Reports -- Forecasts and trends, Chemotherapy -- Forecasts and trends -- Reports -- Statistics, Cancer -- Chemotherapy, Antibodies -- Statistics -- Reports -- Forecasts and trends, Pharmaceutical industry -- Statistics -- Forecasts and trends, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

New York, July 07, Jul 07, 2022 (GLOBE NEWSWIRE via COMTEX) -- EQNX::TICKER_START EQNX::TICKER_END Reportlinker.com announces the release of the report 'Global Antibody Drug Conjugates Market Size, Share & Industry [...]

Published
2022

4. The Global Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market is expected to grow by $ 1.79 bn during 2022-2026 progressing at a CAGR of 7.71% during the forecast period

Subjects
ADC Therapeutics S.A. -- Forecasts and trends, Lymphomas -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

New York, April 18, Apr 18, 2022 (GLOBE NEWSWIRE via COMTEX) -- Reportlinker.com announces the release of the report 'Global Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market 2022-2026' - https://www.reportlinker.com/p05589855/?utm_source=GNW [...]

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results